首页> 外国专利> METHOD AND MEDICAMENT FOR SULFATED POLYSACCHARIDE TREATMENT OF HEPARIN-INDUCED THROMBOCYTOPENIA (HIT) SYNDROME

METHOD AND MEDICAMENT FOR SULFATED POLYSACCHARIDE TREATMENT OF HEPARIN-INDUCED THROMBOCYTOPENIA (HIT) SYNDROME

机译:肝素诱导的血小板减少症(HIT)综合征的硫酸多糖治疗方法和药物

摘要

A method and medicament for treating and preventing platelet activation or thrombosis in the presence of heparin-and platelet factor 4-complex reactive antibodies using a 2-O desulfated heparin with an average degree of sulfation of 0.6 sulfate groups per monosaccharide or greater and an average molecular weight or 2.4 kD or greater. The medicament preferably is administered intravenously, by aerosolization or orally. Preferably, the 2-O desulfated heparin medicament includes a physiologically acceptable carrier which may be selected from the group consisting of physiologically buffered saline, normal saline, and distilled water. Additionally provided is a method of synthesizing 2-O desulfated heparin.
机译:一种在肝素和血小板因子4-复合物反应性抗体存在下使用2-O脱硫肝素治疗和预防血小板活化或血栓形成的方法和药物,其平均硫酸化度为每个单糖0.6个硫酸盐基团或更高分子量大于或等于2.4 kD。该药物优选静脉内,雾化或口服给药。优选地,所述2-O脱硫肝素药物包括生理学可接受的载体,所述载体可以选自生理缓冲盐水,生理盐水和蒸馏水。另外提供了一种合成2-O脱硫肝素的方法。

著录项

  • 公开/公告号EP1807095A4

    专利类型

  • 公开/公告日2008-08-27

    原文格式PDF

  • 申请/专利权人 PARINGENIX INC.;

    申请/专利号EP20050824840

  • 发明设计人 WALENGA JEANINE M.;KENNEDY THOMAS PRESTON;

    申请日2005-10-26

  • 分类号A61K31/727;A61P7;A61P7/02;

  • 国家 EP

  • 入库时间 2022-08-21 19:57:36

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号